530 related articles for article (PubMed ID: 36591215)
1. A transient receptor potential channel-related model based on machine learning for evaluating tumor microenvironment and immunotherapeutic strategies in acute myeloid leukemia.
Hua J; Ding T; Shao Y
Front Immunol; 2022; 13():1040661. PubMed ID: 36591215
[TBL] [Abstract][Full Text] [Related]
2. A novel prognostic model related to oxidative stress for treatment prediction in lung adenocarcinoma.
Peng H; Li X; Luan Y; Wang C; Wang W
Front Oncol; 2023; 13():1078697. PubMed ID: 36798829
[TBL] [Abstract][Full Text] [Related]
3. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
Xu Q; Xu H; Chen S; Huang W
Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
[No Abstract] [Full Text] [Related]
4. Integrated bioinformatic analysis of mitochondrial metabolism-related genes in acute myeloid leukemia.
Tong X; Zhou F
Front Immunol; 2023; 14():1120670. PubMed ID: 37138869
[TBL] [Abstract][Full Text] [Related]
5. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
[TBL] [Abstract][Full Text] [Related]
6. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
7. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
Yue C; Ma H; Zhou Y
PeerJ; 2019; 7():e8128. PubMed ID: 31803536
[TBL] [Abstract][Full Text] [Related]
10. Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma.
Jia Y; Liu R; Shi L; Feng Y; Zhang L; Guo N; He A; Kong G
BMC Cancer; 2023 Sep; 23(1):859. PubMed ID: 37700273
[TBL] [Abstract][Full Text] [Related]
11. Construction of an acute myeloid leukemia prognostic model based on m6A-related efferocytosis-related genes.
Wang Y; Bin T; Tang J; Xu XJ; Lin C; Lu B; Sun TT
Front Immunol; 2023; 14():1268090. PubMed ID: 38077322
[TBL] [Abstract][Full Text] [Related]
12. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
Front Oncol; 2022; 12():915662. PubMed ID: 36033441
[TBL] [Abstract][Full Text] [Related]
13. Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer.
Dong B; Liang J; Li D; Song W; Zhao S; Ma Y; Song J; Zhu M; Yang T
Front Genet; 2021; 12():696912. PubMed ID: 34512722
[No Abstract] [Full Text] [Related]
14. Comprehensive Analysis of TRP Channel-Related Genes for Estimating the Immune Microenvironment, Prognosis, and Therapeutic Effect in Patients With Esophageal Squamous Cell Carcinoma.
Zhao F; Gao S; Qin X; Niu R; Li Z; Wang C; Li S
Front Cell Dev Biol; 2022; 10():820870. PubMed ID: 35309940
[TBL] [Abstract][Full Text] [Related]
15. Identification of the Integrated Prognostic Signature Associated with Immuno-relevant Genes and Long Non-coding RNAs in Acute Myeloid Leukemia.
Zhao C; Wang Y; Sharma A; Wang Z; Zheng C; Wei Y; Wu Y; Liu P; Liu J; Zhan X; Schmidt-Wolf I; Tu F
Cancer Invest; 2022 Sep; 40(8):663-674. PubMed ID: 35770858
[TBL] [Abstract][Full Text] [Related]
16. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
17. A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia.
Zhang HB; Sun ZK; Zhong FM; Yao FY; Liu J; Zhang J; Zhang N; Lin J; Li SQ; Li MY; Jiang JY; Cheng Y; Xu S; Cheng XX; Huang B; Wang XZ
Lipids Health Dis; 2022 Aug; 21(1):79. PubMed ID: 36002858
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive analysis of nucleotide excision repair characteristics defines a novel prognostic signature for acute myeloid leukemia.
Bu XX; Cong J; Ling L; Lu BB; Wu CY; Jiang F; Wang ZM; Chen J
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):6917-6930. PubMed ID: 37606102
[TBL] [Abstract][Full Text] [Related]
19. Analysis of prognostic biomarker models and immune microenvironment in acute myeloid leukemia by integrative bioinformatics.
Wang N
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9609-9619. PubMed ID: 37222809
[TBL] [Abstract][Full Text] [Related]
20. A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia.
Li P; Li J; Wen F; Cao Y; Luo Z; Zuo J; Wu F; Li Z; Li W; Wang F
Front Oncol; 2022; 12():966920. PubMed ID: 36276132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
